+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Egg Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Egg Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Vascular Calcification - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Calcification - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Ocular Inflammation And Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Inflammation And Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
LRRK2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

LRRK2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
RIPK1 Inhibitor - Pipeline Insights, 2025 - Product Thumbnail Image

RIPK1 Inhibitor - Pipeline Insights, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Metastatic Bone Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Bone Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
MELAS Sundrome - Pipeline Insight, 2025 - Product Thumbnail Image

MELAS Sundrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Advanced Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Renal Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
Caspases Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspases Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thrombocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Thrombocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Tardive Dyskinesia - Pipeline Insight, 2025 - Product Thumbnail Image

Tardive Dyskinesia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Systemic Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Resistant Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Resistant Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renal Anemia- Pipeline Insight, 2025 - Product Thumbnail Image

Renal Anemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Oral Mucositis - Pipeline Insight, 2025 - Product Thumbnail Image

Oral Mucositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more